The mechanism of the antiarrhythmic effect of opiate receptor's agonist and antagonist

L. N. Maslov, B. Lishmanov Yu., J. I. Szekely

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Enkephalins were injected intravenously at a dose of 0.1 mg/kg 15 minutes or 6 hours before adrenalin or CaCl2 injection. Enkephalins were reported to prevent adrenal ventricular extrasistoles but not to influence CaCl2-induced dysrhythmias. Maximum antiarrhythmic effect of enkephalins was demonstrated 6 hours later after the intravenous injection. Naloxone at a dose of 2 mg/kg and morphine at a dose of 1.5 mg/kg prevent adrenal arrhythmias 15 min and 6 hours later after injection. We believe that peripheral delta opiate receptors activation by enkephalins as well as the blockade of non-identified opiate receptors by naloxone prevent arrhythmias.

Original languageEnglish
Pages (from-to)169-171
Number of pages3
JournalByulleten Eksperimentalnoi Biologii i Meditsiny
Volume116
Issue number8
Publication statusPublished - 1993

Fingerprint

Enkephalins
Opioid Receptors
Naloxone
Cardiac Arrhythmias
delta Opioid Receptor
Injections
Intravenous Injections
Morphine
Epinephrine
Chemical activation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

The mechanism of the antiarrhythmic effect of opiate receptor's agonist and antagonist. / Maslov, L. N.; Lishmanov Yu., B.; Szekely, J. I.

In: Byulleten Eksperimentalnoi Biologii i Meditsiny, Vol. 116, No. 8, 1993, p. 169-171.

Research output: Contribution to journalArticle

@article{3faae500933e474cb79292f2cfb3f507,
title = "The mechanism of the antiarrhythmic effect of opiate receptor's agonist and antagonist",
abstract = "Enkephalins were injected intravenously at a dose of 0.1 mg/kg 15 minutes or 6 hours before adrenalin or CaCl2 injection. Enkephalins were reported to prevent adrenal ventricular extrasistoles but not to influence CaCl2-induced dysrhythmias. Maximum antiarrhythmic effect of enkephalins was demonstrated 6 hours later after the intravenous injection. Naloxone at a dose of 2 mg/kg and morphine at a dose of 1.5 mg/kg prevent adrenal arrhythmias 15 min and 6 hours later after injection. We believe that peripheral delta opiate receptors activation by enkephalins as well as the blockade of non-identified opiate receptors by naloxone prevent arrhythmias.",
author = "Maslov, {L. N.} and {Lishmanov Yu.}, B. and Szekely, {J. I.}",
year = "1993",
language = "English",
volume = "116",
pages = "169--171",
journal = "Byulleten Eksperimentalnoi Biologii i Meditsiny",
issn = "0365-9615",
publisher = "Rossiiskaya Akademiya Meditsinskikh Nauk",
number = "8",

}

TY - JOUR

T1 - The mechanism of the antiarrhythmic effect of opiate receptor's agonist and antagonist

AU - Maslov, L. N.

AU - Lishmanov Yu., B.

AU - Szekely, J. I.

PY - 1993

Y1 - 1993

N2 - Enkephalins were injected intravenously at a dose of 0.1 mg/kg 15 minutes or 6 hours before adrenalin or CaCl2 injection. Enkephalins were reported to prevent adrenal ventricular extrasistoles but not to influence CaCl2-induced dysrhythmias. Maximum antiarrhythmic effect of enkephalins was demonstrated 6 hours later after the intravenous injection. Naloxone at a dose of 2 mg/kg and morphine at a dose of 1.5 mg/kg prevent adrenal arrhythmias 15 min and 6 hours later after injection. We believe that peripheral delta opiate receptors activation by enkephalins as well as the blockade of non-identified opiate receptors by naloxone prevent arrhythmias.

AB - Enkephalins were injected intravenously at a dose of 0.1 mg/kg 15 minutes or 6 hours before adrenalin or CaCl2 injection. Enkephalins were reported to prevent adrenal ventricular extrasistoles but not to influence CaCl2-induced dysrhythmias. Maximum antiarrhythmic effect of enkephalins was demonstrated 6 hours later after the intravenous injection. Naloxone at a dose of 2 mg/kg and morphine at a dose of 1.5 mg/kg prevent adrenal arrhythmias 15 min and 6 hours later after injection. We believe that peripheral delta opiate receptors activation by enkephalins as well as the blockade of non-identified opiate receptors by naloxone prevent arrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=0027765544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027765544&partnerID=8YFLogxK

M3 - Article

VL - 116

SP - 169

EP - 171

JO - Byulleten Eksperimentalnoi Biologii i Meditsiny

JF - Byulleten Eksperimentalnoi Biologii i Meditsiny

SN - 0365-9615

IS - 8

ER -